Pharmaceuticals

Cardiac Biomarkers Testing Market Forecast to Reach $25.92 Billion by 2030 at 11.6% CAGR

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Cardiac Biomarkers Testing Market From 2026 To 2030?

The cardiac biomarkers testing market size has demonstrated rapid expansion in recent years. It is projected to increase from $14.95 billion in 2025 to $16.7 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The market’s historical growth can be attributed to the rising incidence of cardiovascular diseases, greater awareness of cardiac health, progress in laboratory diagnostics, expanding hospital infrastructure, and an increase in government healthcare initiatives.

The cardiac biomarkers testing market is projected to experience substantial expansion over the upcoming years, with its valuation anticipated to reach $25.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.6%. This anticipated growth during the forecast timeframe is attributable to factors such as the integration of AI in diagnostic processes, the increase in home-based and remote monitoring solutions, advancements in precision medicine, the creation of multi-biomarker panels, and the escalating need for real-time cardiac surveillance. Key developments expected during this period encompass the widespread use of point-of-care testing, the emergence of miniaturized and portable diagnostic instruments, innovations in biomarker multiplexing technologies, bespoke cardiac risk assessments, and the incorporation of wearable devices for heart monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp

What Key Drivers Are Influencing The Growth Of The Cardiac Biomarkers Testing Market?

The growing incidence of cardiovascular diseases is anticipated to stimulate the expansion of the cardiac biomarkers testing market moving forward. Cardiovascular disease refers to medical conditions that affect the heart or its associated blood vessels. Cardiac biomarker tests are instrumental in measuring biomarker levels to swiftly determine the severity and extent of a heart attack. Hence, a greater occurrence of cardiovascular diseases will lead to increased demand for cardiac biomarker testing solutions. For example, in January 2024, the American Heart Association, a US-based non-profit organization, indicated that the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. Therefore, the rising prevalence of cardiovascular diseases is serving as a significant driver for the growth of the cardiac biomarkers testing market.

Which Segments Are Included In The Analysis Of The Cardiac Biomarkers Testing Market?

The cardiac biomarkers testing market covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types

2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications

3) By End-User: Hospitals, Specialty Clinics

Which Trends Are Impacting The Growth Of The Cardiac Biomarkers Testing Market?

Key players in the cardiac biomarker testing market are forming strategic alliances to supply technology aimed at detecting early signs of heart conditions and improving patient results. These strategic partnerships in cardiac biomarker testing stimulate cooperation between businesses, enabling the development of innovative diagnostic tools, expanding their market reach, and accelerating the provision of advanced testing solutions for enhanced cardiovascular care. For instance, in September 2024, MediBuddy, an India-based healthcare technology company that offers a comprehensive platform for telehealth services, health management, and insurance assistance, entered a partnership with Philips, a Netherlands-based conglomerate corporation. Through this collaboration, they seek to improve cardiac care in India by incorporating Philips’ HeartPrint technology, which allows for regular monitoring and risk assessment of heart health. This proactive approach provides users with sophisticated tools on the MediBuddy platform, encouraging anticipatory management of heart health and better outcomes.

Which Key Industry Participants Are Active In The Cardiac Biomarkers Testing Market?

Major companies operating in the cardiac biomarkers testing market are Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation

Read the full cardiac biomarkers testing market report here:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Cardiac Biomarkers Testing Market?

North America was the largest region in the cardiac biomarkers testing market in 2025. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cardiac Biomarkers Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9436&type=smp

Browse Through More Reports Similar to the Global Cardiac Biomarkers Testing Market 2026, By The Business Research Company

Cardiac Biomarkers Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Cardiac Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Clinical Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795